There is a diabetes study being conducted by Harvard University that looks pretty promising using cells from an embryo to generate insulin for people whose islet cells have been attacked and destroyed by the body's immune system. The last remaining issue for them is to find a delivery platform that will skirt the immune system. Can you say Cell in a Box? This technology is going to have many major applications in the medical field.
News 
Market Data 
Discover 
